Using Medrio’s eClinical Software as a Service (SaaS) suite, bioskin is able to provide clients a user-friendly, efficient and cost-effective solution for data collection.
"Our data managers are able to build the study themselves, without losing valuable time communicating with external programmers. The advantage for the client is faster implementation of a study database," said Walter Wigger-Alberti, CEO of bioskin.
bioskin’s partnership with Medrio will help deliver the best possible experience for customers.
"We are thrilled to add bioskin to Medrio’s partner program," added Scott Weidley, Vice President of Sales and Marketing at Medrio.
"Over the past year, we’ve worked closely with bioskin and look forward to continuing our collaboration through our partnership."
bioskin is a full-service CRO specialized in dermatology and related indications. We offer strategic planning and regulatory support for global dermatological product development as well as all core operational services for management of Phase I-IV clinical trials and medical device trials.